Ibuprofen API Market 2023 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

The global market value of ibuprofen API market was USD 675.1 million in 2022, and CAGR of 3.2% is expected during the forecast period. Due to the increase in pharmaceutical, and biopharmaceutical industry is driving the growth in the ibuprofen market. Active pharmaceutical ingredients are bulk medicinal products, which are used in basic materials in pharmaceutical formulations. Increasing incidences of wide range of illness, specially heart disorder is driving the growth in the market significantly. Rising number of cases of diabetes, kidney disorder among all age group people is driving the growth in the market. Increasingly effectiveness in women healthcare, and better results as a pain reliever is driving the growth in ibuprofen API market.

Impact of Covid-19

Due to the disruption in supply chain, and transportation delay the market faced a slowdown. Increased demand for medications during the pandemic increased the demand, but due to restrictions on manufacturing had negatively impacted the market. Increased focus on healthcare preparedness and changing consumer behavior is also influencing the market dynamics. But later on, with the telehealth consultation started for every other disease except covid-19, the demand for the ibuprofen increased drastically. Increasing effectiveness along with efficiency is driving the growth in the market.

Growth Drivers

Increasing incidence of pain related conditions, and chronic diseases, have amplified the demand for ibuprofen. As the population ages, there is a rising prevalence of age-related health issues, like arthritis, contributing to sustained demand for ibuprofen-based medications. Ongoing research and development activities have led to an innovation in drug delivery system and formulation, enhancing the effectiveness, and usability of ibuprofen. Expansion of pharmaceuticals sector specially in emerging markets have boosted the growth in the market. Growing awareness of health all around the world, including the special care about the chronic diseases is driving the growth in the market.

Excess use of pain reliever all around the world is driving the growth in the market.

Segmentation

Type

·         Standard Ibuprofen

·         High Potency Ibuprofen

Applications

·         Pharmaceuticals

·         Tablets

·         Capsules

·         Suspensions

·         Cosmetics and Industrial

·         Others

End-User

·         Hospitals

·         Clinics

·         Pharmacies

·         Research Institutes

Distribution Channel

·         Hospitals

·         Wholesalers

·         Retail Pharmacies

·         Online Sales Platform

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Europe

·         Middle East and Africa

Ibuprofen API Market type Segmentation

On the basis of type, ibuprofen market is segmented into standard ibuprofen, and high potency ibuprofen. Standard ibuprofen refers to the regular or commonly available strength of ibuprofen, which is often 200 mg per tablet or capsule. It is commonly used for moderate to mild pain relief, fever reduction, and anti-inflammatory purposes. High potency ibuprofen formulations with higher doses per unit, such as 400 mg or 600 mg, or even 800 mg per tablet or capsules. These higher doses are typically prescribed for more severe pain or inflammation. Rising cases of Rheumatoid Arthritis in populous countries like India, and China are driving the growth in the market. India is 3^rd largest ibuprofen manufacturer in the world, thus a very big exporter India is. Low manufacturing cost have attracted the pharmaceutical companies worldwide.

Ibuprofen API Market Distribution Channel Segmentation

On the basis of distribution channel, the Ibuprofen API Market is segmented into Hospitals, Wholesalers, Retail Pharmacies, and Online Sales Platform. Hospitals are the leading segment due to their easy availability, and accessibility. Number of patients approaching the hospitals suffering from chronic diseases are driving the growth in the market. Retail pharmacies are other segment, which are leading the business, online sales platform is expected to dominate during the forecast period.

Ibuprofen API Market Application Segmentation

On the basis of the application, Ibuprofen API market is segmented into pharmaceuticals, tablets, capsules, suspension, cosmetics, and industrial and others. Pharmaceuticals are the leading segment, and tablets or capsules are other segment, expected to dominate the market worldwide. Suspensions are suitable for kids, and increasing demand for the ibuprofen in cosmetic products, or industrial is driving the growth in the market significantly.

Regional Outlook

On the basis of the regions, the Ibuprofen API market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East and Africa. The Asia pacific region due to the high population of India, and China is leading the market in the region. Increasing geriatric population, and rising number of chronic disease patients, and auto-immune disease is driving the growth in the market. Rising urbanization, and increasing disposable income of the people is responsible for driving the growth in the region. Increasing health awareness, and increasing inclination towards better health infrastructure is driving the growth in the market significantly. North America is the second big market due to the presence of United States of America, and Canada.

Best healthcare infrastructure in the region is driving the growth in the market. Increasing number of healthcare centers along with increasing health facilities in all over the continent is driving the growth of the ibuprofen market in the region. Europe due to the presence of key market players, and the focus on quality product along with stringent regulatory compliance, is the big market in ibuprofen. Increasing geriatric population in European countries like England, Italy, France, and Germany is driving the growth in the market. Increasing demand for ibuprofen in cosmetics, and pharmaceuticals is driving the growth in the market. Ibuprofen is a very old pain reliever used in most part of the world.

Middle East and Africa is witnessing moderate growth due to the presence of big healthcare centers in Dubai, and Abu Dhabi. Latin America market is witnessing slow growth due to the poor healthcare infrastructure in the region. Brazil, Argentina, and most of the part of the middle east region is far from the development in health infrastructure, and is expected to witness the growth during the forecast period. Increasing inclination of worldwide governments, and NGOs are trying their best for the development in Ibuprofen API market.

Key Players

·         Granules India Limited

·         Solara Active Pharma Science Limited

·         BASF SE

·         SI Group INC

·         IOL Chemicals and Pharmaceuticals Limited

·         Sino-US Zibo Xinhua-Perrigo Pharmaceuticals co. ltd

·         Biocause INC

·         IPLCP

·         SI Group

·         Shasun Pharmaceuticals Limited

·         Other players